Korean Circ J.  2020 Dec;50(12):1074-1076. 10.4070/kcj.2020.0434.

Finding Cardiac Resynchronization Therapy Responders: Postprocedural QRS-T Morphologies Matter

• Kim M
• Kim TH

• KMID: 2509026
• DOI: http://doi.org/10.4070/kcj.2020.0434

Reference

1. O'Brien T, Park MS, Youn JC, Chung ES. The past, present and future of cardiac resynchronization therapy. Korean Circ J. 2019; 49:384–399. PMID: 31074211.

2. Lee JH, Lee SR, Choi EK, et al. Temporal trends of cardiac implantable electronic device implantations: a nationwide population-based study. Korean Circ J. 2019; 49:841–852. PMID: 31074230.

3. Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016; 37:2129–2200. PMID: 27206819.

4. Hsu JC, Solomon SD, Bourgoun M, et al. Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study. J Am Coll Cardiol. 2012; 59:2366–2373. PMID: 22698490.

5. Rickard J, Cheng A, Spragg D, et al. QRS narrowing is associated with reverse remodeling in patients with chronic right ventricular pacing upgraded to cardiac resynchronization therapy. Heart Rhythm. 2013; 10:55–60. PMID: 23000040.

6. Bode WD, Bode MF, Gettes L, Jensen BC, Mounsey JP, Chung EH. Prominent R wave in ECG lead V1 predicts improvement of left ventricular ejection fraction after cardiac resynchronization therapy in patients with or without left bundle branch block. Heart Rhythm. 2015; 12:2141–2147. PMID: 26048194.

7. Jing R, Jin H, Hua W, Yang S, Hu Y, Zhang S. Association between subcutaneous implantable cardioverter defibrillator preimplantation screening and the response to cardiac resynchronization therapy. Korean Circ J. 2020; 50:1062–1073.

8. Zeb M, Curzen N, Allavatam V, et al. Sensitivity and specificity of the subcutaneous implantable cardioverter defibrillator pre-implant screening tool. Int J Cardiol. 2015; 195:205–209. PMID: 26048376.

9. Mafi Rad M, Wijntjens GW, Engels EB, et al. Vectorcardiographic QRS area identifies delayed left ventricular lateral wall activation determined by electroanatomic mapping in candidates for cardiac resynchronization therapy. Heart Rhythm. 2016; 13:217–225. PMID: 26232766.

10. Mandel WJ, Burgess MJ, Neville J Jr, Abildskov JA. Analysis of T-wave abnormalities associated with myocardial infarction using a theoretic model. Circulation. 1968; 38:178–188. PMID: 11712287.